In this study, a novel mammarenavirus (family Arenaviridae) was identified in a hedgehog (family Erinaceidae) in Hungary and genetically characterized. Mecsek Mountains virus (MEMV, OP191655, OP191656) was detected in nine (45%) out of 20 faecal specimens collected from a Northern white-breasted hedgehog (Erinaceus roumanicus). The L-segment proteins (RdRp and Z) and S-segment proteins (NP and GPC) of MEMV had 67.5%/70% and 74.6%/65.6% amino acid sequence identity, respectively, to the corresponding proteins of Alxa virus (species Mammarenavirus alashanense) identified recently in an anal swab from a three-toed jerboa (Dipus sagitta) in China. MEMV is the second known arenavirus endemic in Europe.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250479 | PMC |
| http://dx.doi.org/10.1007/s00705-023-05804-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Novel coronaviruses and mammarenaviruses of hedgehogs from Russia including the comparison of viral communities of hibernating and active specimens.
Front Vet Sci
December 2024
Laboratory of Multiomics Research, Scientific Research Institute for Systems Biology and Medicine, Federal Service on Consumer Rights Protection and Human Well-Being Surveillance, Moscow, Russia.
Introduction: Small mammals, especially rodents and bats, are known reservoirs of zoonotic viruses, but little is known about the viromes of insectivorous species including hedgehogs (order Eulipotyphla), which often live near human settlements and come into contact with humans.
Methods: We used high-throughput sequencing and metaviromic analysis to describe the viromes of 21 hedgehogs (Erinaceus sp.) sampled from summer 2022 to spring 2023.
Mammarenaviruses are noteworthy zoonotic pathogens, and the main reservoirs are rodent species. We report the detection of a novel mammarenavirus in 6/183 (3.3%) in necropsied European hedgehogs (Erinaceus europaeus) collected in Italy.
View Article and Find Full Text PDFU-73122, a phospholipase C inhibitor, impairs lymphocytic choriomeningitis virus virion infectivity.
J Gen Virol
December 2024
Laboratory of Emerging Viral Diseases, International Research Center for Infectious Diseases, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
Lassa virus (LASV) is an Old World (OW) mammarenavirus that causes Lassa fever, a life-threatening acute febrile disease endemic in West Africa. Lymphocytic choriomeningitis virus (LCMV) is a worldwide-distributed, prototypic OW mammarenavirus of clinical significance that has been largely neglected as a human pathogen. No licensed OW mammarenavirus vaccines are available, and the current therapeutic option is limited to the off-label use of ribavirin, which offers only partial efficacy.
View Article and Find Full Text PDFIn Vivo CRISPR Screening Reveals CHD7 as a Positive Regulator of Short-lived Effector Cells.
J Immunol
November 2024
Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA.
CD8+ T cells differentiate into two subpopulations in response to acute viral infection: memory precursor effector cells (MPECs) and short-lived effector cells (SLECs). MPECs and SLECs are epigenetically distinct; however, the epigenetic regulators required for formation of these subpopulations are mostly unknown. In this study, we performed an in vivo CRISPR screen in murine naive CD8+ T cells to identify the epigenetic regulators required for MPEC and SLEC formation, using the acute lymphocytic choriomeningitis virus Armstrong infection model.
View Article and Find Full Text PDFSimultaneous screening for selective SARS-CoV-2, Lassa, and Machupo virus entry inhibitors.
SLAS Discov
September 2024
Department of Molecular Medicine, Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, 130 Scripps Way, Jupiter, FL 33458, United States. Electronic address:
Article Synopsis
- Emerging highly pathogenic viruses, such as SARS-CoV-2, Lassa virus, and Machupo virus, pose significant risks to global health, prompting initiatives like the establishment of Antiviral Drug Discovery centers by NIAID.
- Researchers developed paired entry assays to screen approximately 650,000 compounds using a dual pseudotyped virus infection system, achieving an extensive ultra-high throughput screening with over 2.4 million wells tested.
- The screening identified a total of 1812, 1506, and 2586 unique hits for LASV, MACV, and SARS2, respectively, and confirmed several promising compounds with low cytotoxicity and strong antiviral activity, with some compounds showing IC
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!